Talimogene laherparepvec: First in class oncolytic virotherapy

Robert M. Conry, Brian Westbrook, Svetlana McKee, Timothy Graham Norwood
  • Human Vaccines & Immunotherapeutics, February 2018, Taylor & Francis
  • DOI: 10.1080/21645515.2017.1412896

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/21645515.2017.1412896

In partnership with: